This content is from: Premium

Trian’s Bold DuPont Campaign — So Crazy It Just Might Work?

While the activist investor owns a small percentage of the company, it is agitating for big changes. But if other hedge fund firms’ recent campaigns are a guide, Trian may get at least some of what it wants.

       Nelson Peltz, Trian Fund Management (Bloomberg)At first glance, New York–based activist hedge fund firm Trian Fund Management’s planned proxy fight with DuPont in a bid to gain four board seats may seem a little audacious and risky. After all, the venerable chemical giant boasts a market capitalization of about $60 billion

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content